{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:16:14Z","timestamp":1789474574091,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH120168"],"award-info":[{"award-number":["R01MH120168"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R41MH113398"],"award-info":[{"award-number":["R41MH113398"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R43 MH097370"],"award-info":[{"award-number":["R43 MH097370"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R0!MH120168"],"award-info":[{"award-number":["R0!MH120168"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH120168"],"award-info":[{"award-number":["R01MH120168"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012462","name":"Department of Veterans Affairs | Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX001149"],"award-info":[{"award-number":["BX001149"]}],"id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012462","name":"Department of Veterans Affairs | Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX004475"],"award-info":[{"award-number":["BX004475"]}],"id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41380-025-02941-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:54:53Z","timestamp":1741082093000},"page":"3551-3559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A simple platelet biomarker is associated with symptom severity in major depressive disorder"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2728-1135","authenticated-orcid":false,"given":"Aksu","family":"Gunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-5197","authenticated-orcid":false,"given":"Steven D.","family":"Targum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D.","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-0437","authenticated-orcid":false,"given":"Olusola","family":"Ajilore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-4364","authenticated-orcid":false,"given":"Mark M.","family":"Rasenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2941_CR1","volume-title":"StatPearls [Internet]","author":"N Bains","year":"2024","unstructured":"Bains N, Abdijadid S. Major depressive disorder. StatPearls [Internet]. Treasure Island (FL): StatPearls [Internet]; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559078\/"},{"key":"2941_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","volume":"39","author":"PE Greenberg","year":"2021","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39:653\u201365.","journal-title":"Pharmacoeconomics"},{"key":"2941_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163:1905\u201317.","journal-title":"Am J Psychiatry"},{"key":"2941_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrn2059","volume":"8","author":"JA Allen","year":"2007","unstructured":"Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"2941_CR5","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1523\/JNEUROSCI.3033-19.2020","volume":"40","author":"H Singh","year":"2020","unstructured":"Singh H, Chmura J, Bhaumik R, Pandey GN, Rasenick MM. Membrane-associated \u03b1-tubulin is less acetylated in postmortem prefrontal cortex from depressed subjects relative to controls: cytoskeletal dynamics, HDAC6, and depression. J Neurosci. 2020;40:4033\u201341.","journal-title":"J Neurosci"},{"key":"2941_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1124\/mol.109.060160","volume":"76","author":"JA Allen","year":"2009","unstructured":"Allen JA, Yu JZ, Dave RH, Bhatnagar A, Roth BL, Rasenick MM. Caveolin-1 and lipid microdomains regulate Gs trafficking and attenuate Gs\/adenylyl cyclase signaling. Mol Pharmacol. 2009;76:1082\u201393.","journal-title":"Mol Pharmacol"},{"key":"2941_CR7","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41380-021-01399-1","volume":"27","author":"SD Targum","year":"2022","unstructured":"Targum SD, Schappi J, Koutsouris A, Bhaumik R, Rapaport MH, Rasgon N, et al. A novel peripheral biomarker for depression and antidepressant response. Mol Psychiatry. 2022;27:1640\u20136. https:\/\/www.nature.com\/articles\/s41380-021-01399-1","journal-title":"Mol Psychiatry"},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1523\/JNEUROSCI.5713-07.2008","volume":"28","author":"RJ Donati","year":"2008","unstructured":"Donati RJ, Dwivedi Y, Roberts RC, Conley RR, Pandey GN, Rasenick MM. Postmortem brain tissue of depressed suicides reveals increased Gs\u03b1 localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci. 2008;28:3042\u201350.","journal-title":"J Neurosci"},{"key":"2941_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1046\/j.1471-4159.1995.64020724.x","volume":"64","author":"J Chen","year":"1995","unstructured":"Chen J, Rasenick MM. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem. 1995;64:724\u201332.","journal-title":"J Neurochem"},{"key":"2941_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1046\/j.1471-4159.1999.0731114.x","volume":"73","author":"S Toki","year":"1999","unstructured":"Toki S, Donati RJ, Rasenick MM. Treatment of C6 glioma cells and rats with antidepressant drugs increases the detergent extraction of G(s alpha) from plasma membrane. J Neurochem. 1999;73:1114\u201320.","journal-title":"J Neurochem"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/npp.2014.256","volume":"40","author":"AH Czysz","year":"2015","unstructured":"Czysz AH, Schappi JM, Rasenick MM. Lateral diffusion of G\u03b1s in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains. Neuropsychopharmacology. 2015;40:766\u201373.","journal-title":"Neuropsychopharmacology"},{"key":"2941_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1124\/jpet.109.162644","volume":"332","author":"L Zhang","year":"2010","unstructured":"Zhang L, Rasenick MM. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound. J Pharmacol Exp Ther. 2010;332:977\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"2941_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tips.2004.01.003","volume":"25","author":"JM O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell JM, Zhang HT. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci. 2004;25:158\u201363.","journal-title":"Trends Pharmacol Sci"},{"key":"2941_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.31887\/DCNS.2008.10.4\/gracagni","volume":"10","author":"G Racagni","year":"2008","unstructured":"Racagni G, Popoli M. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci. 2008;10:385\u2013400.","journal-title":"Dialogues Clin Neurosci"},{"key":"2941_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.biopsych.2005.05.040","volume":"58","author":"LM Hines","year":"2005","unstructured":"Hines LM, Tabakoff B, WHO\/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence Investigators. Platelet adenylyl cyclase activity: a biological marker for major depression and recent drug use. Biol Psychiatry. 2005;58:955\u201362.","journal-title":"Biol Psychiatry"},{"key":"2941_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0006-3223(88)90002-9","volume":"23","author":"JJ Mooney","year":"1988","unstructured":"Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, et al. Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol Psychiatry. 1988;23:543\u201359.","journal-title":"Biol Psychiatry"},{"key":"2941_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0773.1985.tb02500.x","volume":"56","author":"GN Pandey","year":"1985","unstructured":"Pandey GN, Sudershan P, Davis JM. Beta adrenergic receptor function in depression and the effect of antidepressant drugs. Acta Pharmacol Toxicol. 1985;56:66\u201379.","journal-title":"Acta Pharmacol Toxicol"},{"key":"2941_CR18","doi-asserted-by":"publisher","first-page":"15693","DOI":"10.1074\/jbc.270.26.15693","volume":"270","author":"S Li","year":"1995","unstructured":"Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, et al. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem. 1995;270:15693\u2013701.","journal-title":"J Biol Chem"},{"key":"2941_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.6849117","volume":"219","author":"DB Menkes","year":"1983","unstructured":"Menkes DB, Rasenick MM, Wheeler MA, Bitensky MW. Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science. 1983;219:65\u20137.","journal-title":"Science"},{"key":"2941_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0026-895X(25)09657-9","volume":"36","author":"H Ozawa","year":"1989","unstructured":"Ozawa H, Rasenick MM. Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol. 1989;36:803\u20138.","journal-title":"Mol Pharmacol"},{"key":"2941_CR21","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1038\/s41380-020-0724-6","volume":"26","author":"P Chukaew","year":"2021","unstructured":"Chukaew P, Leow A, Saengsawang W, Rasenick MM. Potential depression and antidepressant-response biomarkers in human lymphoblast cell lines from treatment-responsive and treatment-resistant subjects: roles of SSRIs and omega-3 polyunsaturated fatty acids. Mol Psychiatry. 2021;26:2402\u201314.","journal-title":"Mol Psychiatry"},{"key":"2941_CR22","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/sj.npp.1300697","volume":"30","author":"RJ Donati","year":"2005","unstructured":"Donati RJ, Rasenick MM. Chronic antidepressant treatment prevents accumulation of Gs\u03b1 in cholesterol-rich, cytoskeletal-associated, plasma membrane domains (Lipid Rafts). Neuropsychopharmacology. 2005;30:1238\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"2941_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/s41380-018-0083-8","volume":"24","author":"NH Wray","year":"2019","unstructured":"Wray NH, Schappi JM, Singh H, Senese NB, Rasenick MM. NMDAR-independent, cAMP-dependent antidepressant actions of ketamine. Mol Psychiatry. 2019;24:1833\u201343.","journal-title":"Mol Psychiatry"},{"key":"2941_CR24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1124\/mol.104.008342","volume":"67","author":"JA Allen","year":"2005","unstructured":"Allen JA, Yu JZ, Donati RJ, Rasenick MM. Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells. Mol Pharmacol. 2005;67:1493\u2013504.","journal-title":"Mol Pharmacol"},{"key":"2941_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/mp.2016.171","volume":"22","author":"M Fujita","year":"2017","unstructured":"Fujita M, Richards EM, Niciu MJ, Ionescu DF, Zoghbi SS, Hong J, et al. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Mol Psychiatry. 2017;22:754\u20139.","journal-title":"Mol Psychiatry"},{"key":"2941_CR26","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333. Suppl 20","journal-title":"J Clin Psychiatry"},{"key":"2941_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2941_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573\u201383.","journal-title":"Biol Psychiatry"},{"key":"2941_CR29","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1074\/jbc.M116.727263","volume":"291","author":"SJ Erb","year":"2016","unstructured":"Erb SJ, Schappi JM, Rasenick MM. Antidepressants accumulate in lipid rafts independent of monoamine transporters to modulate redistribution of the G protein, G\u03b1s. J Biol Chem. 2016;291:19725\u201333.","journal-title":"J Biol Chem"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02941-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:08:01Z","timestamp":1757142481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02941-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02941-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (1964) and Good Clinical Practices as outlined by the International Conference on Harmonization (1997). This study was approved by the Institutional Review Board of the University of Illinois Chicago (Study #2019-1333). Participants provided written informed consent prior to participating in study procedures and completed an additional electronic consent for the BiAffect app. All participants signed an IRB-approved consent to participate and consent to give blood samples for the UnMASCK study. All participating subjects were compensated for their participation in the study. Methods are used in this study conform to all international, federal, state, local and university guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Dr. Targum has received vendor grants and\/or consulting fees from Actinogen Medical Ltd., BioXcel Therapeutics, CSA Medical Inc., Deerfield Discovery and Development, LLC, EMA Wellness, ERG Inc., Frequency Therapeutics, Functional Neuromodulation Inc., Karuna Pharmaceuticals, Maplight, Merck Pharmaceuticals, Navitor-Supernus Pharmaceuticals, Neurocrine Bioscience, Pax Neuroscience, and Signant Health during the past 3 years. Dr. Ajilore is a co-founder of KeyWIse AI. He also serves on the advisory boards of Embodied Labs, Sage Therapeutics and Blueprint Health. He is also a consultant for Otsuka. Dr. Leow is an advisor for Buoy health and a consultant for Otsuka USA and ATAI Life Sciences, in addition to being a co-founder of KeyWise AI. Dr. Rasenick is co-founder and chief scientific officer of Pax Neuroscience. In the past three years he has consulted for Otsuka, Inc and has received research support from Lundbeck SA. He is also supported by grants from the Veterans Administration and is a research career scientist of the VA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}